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Introduction
Neuropsychiatric involvement in cSLE has a prevalence
ranging from 20 to 95% and results in significant morbid-
ity and mortality. Multiple autoantibodies have been
reported in association with NPSLE. Anti-P seem to be
highly specific for SLE and might also be a marker for SLE
disease activity. In SLE population the prevalence of anti-P
varies from 6% a 46% depending on ethnicity, age and
clinical variables analyzed. Anti-P are able to binding neu-
ronal cells of the limbic areas that are associated whit
olfaction. Decreased olfaction was observed in patients
with several central nervous system CNS diseases in which
immune-mediated mechanisms have been implicated.
Evidence that olfactory dysfunction is an early sign of neu-
rologic diseases makes a patient’s sense of smell of direct
relevance to the neurologist
Objectives
To assess the olfactory functions in cSLE patients com-
pared with age- and sex-matched healthy controls, to
examine the association between the sense of smell, anti-P,
disease activity, damage and CNS involvement.
Methods
Olfactory functions were evaluated using the Sniffin’ Sticks
test. All individuals were submitted to a standardized neu-
ropsychiatric evaluation. Mood disorders were determined
through Becks Depression and Becks Anxiety Inventory
(BDI and BAI). Active neuropsychiatric lupus was diag-
nosed according to ACR guidelines. In SLE, disease activ-
ity was evaluated through SLE Disease Activity Index
(SLEDAI), damage through Systemic Lupus International
Collaborating Clinics/American College of Rheumatology
Damage Index (SLICC-SDI). Anti-P was measured by
ELISA kits. p<0.05 was considered significant.
Results
We included 61 patients (91.8% women) mean age of SLE
patients was 17.51+- 3.42 years and 61 controls matched
for age and sex (p=0.701). Smell deficit correlated with
duration of disease (r=-0.295; p<0.05) and anxiety
(r=0.279; p<0.05). A decrease in the sense of smell was
observed in cSLE patients (31.14%) and controls (27.87%)
(p=0.697). Not observed anosmia in both the cSLE and
control groups. Patients had an average of 31.26 +- 4.47
total points at the 3 stages of Sniffin’ Sticks test while the
controls had mean of 33.28 +- 5.28 points (p<0.05). The
olfactory alteration was not correlated with depression
(r=0.055; p=0.678), SLICC (r=0.777; p<-0.042), SLEDAI
(r=-0.118; p=0.419), CNS involvement (p=0.586) and
alterations olfactory (p=0.518). Anti-ribosomal P antibo-
dies were identified exclusively in SLE patients and were
present in 15 (24.59%) of them. Anti-ribosomal P antibo-
dies were not associated with CNS involvement (p=0.561),
but when we analyzed each manifestation separately, we
only observed an association between the presence of anti-
ribosomal P antibodies and convulsion (p<0.05).
Conclusion
Comparing cSLE patients and matched controls, we
observed a significant decrease in the olfactory abilities in
cSLE patients, which was correlated with duration of dis-
ease and CNS manifestations. Anti-P are predominantly
found in the serum of patients suffering from lupus with
neuropsychiatric involvement, especially psychosis in
adults, therefore, monitoring longitudinal these patients isDepartment of Medicine, Rheumatology Unit, Unicamp, Campinas, Brazil
Peres et al. Pediatric Rheumatology 2014, 12(Suppl 1):P312
http://www.ped-rheum.com/content/12/S1/P312
© 2014 Peres et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
needed for see whether will present during the disease
neuropsychiatric manifestations and if decline olfactory
might be a useful and easy tool for the physician in early
diagnosis of CNS involvement in autoimmune diseases.
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